This page has been archived on the Web

Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.

Archived

This page has been archived on the Web.

Health product recall

Prolia (denosumab) (2013-09-24)

Starting date:
September 24, 2013
Posting date:
October 18, 2013
Type of communication:
Drug Recall
Subcategory:
Drugs
Hazard classification:
Type II
Source of recall:
Health Canada
Issue:
Product Safety
Audience:
General Public, Healthcare Professionals, Hospitals
Identification number:
RA-36025

Recalled Products

Prolia (denosumab) 

Reason

One lot of Prolia, lot 1035671 (packaged from Prolia batch 0010136386) is subject to a recall, after identifying the presence of particulate (cellulose) matter in a small number of pre-filled syringes.

Depth of distribution

Wholesalers in all provinces in Canada.

Affected products

Prolia (denosumab) 

DIN, NPN, DIN-HIM
DIN 02343541
Dosage form

Solution for injection

Strength
  • 60 mg/mL (single-use prefilled syringe)
Lot or serial number

Lot # 1035671*

  • *lot packaged from Prolia batch 0010136386
Companies
Recalling Firm
Amgen Canada Inc.
100 - 6775 Financial Drive
Mississauga
L5N 0A4
Ontario
CANADA
Marketing Authorization Holder
Amgen Canada Inc.
100 - 6775 Financial Drive
Mississauga
L5N 0A4
Ontario
CANADA

Date modified: